NorPedMed is the Norway National Hub in c4c, and the secretariat has been strengthened accordingly with additional resources allocated to take care of our obligations within the c4c. NorPedMed was founded in 2013 to link the paediatric Clinical Trial Units (CTUs) at the six university hospitals. The basic infrastructure of these CTUs (e.g., nurses, housing,…
Detailsc4c outreach to patient advocates nationally- Webinar for the Dutch EUPATI-NL community VSOP, the Dutch Patient Alliance for Rare and Genetic Diseases, is participating in the c4c cross-cutting team for Patient and Public Involvement (PPI), which is working on implementation of patient and public involvement activities across Europe. VSOP was invited by the EUPATI-NL project…
DetailsMeet the team behind c4c! We are a diverse group of people from many different backgrounds, but all of us are working towards a common goal: better medicines for children through European clinical trials. Today’s spotlight is on Sofia Jacob, who oversees multiple activities within c4c to ensure they are completed in time. Sofia…
DetailsCall for Experts 2022 In order to expand our database we are now seeking experts interested to be part of Clinical or Methodology Expert Groups and who want to contribute at providing advice. One task of the c4c consortium is to deliver the scientific feasibility advice needed to improve child health and paediatric…
DetailsHow paediatric drug development and use could benefit from OMICs: A c4c expert group white paper – Neumann – – British Journal of Clinical Pharmacology – Wiley Online Library The safety and efficacy of pharmacotherapy in children, particularly preterms, neonates and infants, is limited by a paucity of good-quality data from prospective clinical drug trials.…
Details
